Concepedia

Thomas H. Kalantar

TH

Statistics

Publications

13

Citations

668

H-Index

12

Active since

1985

Affiliations

Dow Chemical (United States)(Current)

Massachusetts Institute of Technology

Thomas H. Kalantar is an author at Dow Chemical (United States) specializing in natural sciences, chemistry, and pharmaceutical formulation.

Publications per year

1985–2021

13

Publications

13

Conversion of serine to stereochemically pure .beta.-substituted .alpha.-amino acids via .beta.-lactones

Lee D. Arnold, Thomas H. Kalantar, John C. Vederas · Journal of the American Chemical Society · 1985 · 180 citations

Natural Sciences, Biochemistry, Chemistry +11

Properties and Applications of Microemulsions

John Klier, Christopher J. Tucker, Thomas H. Kalantar et al. · Advanced Materials · 2000 · 157 citations

Engineering, Chemical Engineering, Drug Delivery +16

Documenting the scope of the catalytic asymmetric dihydroxylation

Braj B. Lohray, Thomas H. Kalantar, B. Moon Kim et al. · Tetrahedron Letters · 1989 · 96 citations

Natural Sciences, Biochemistry, Chemistry +12

Analogs of diaminopimelic acid as inhibitors of meso-diaminopimelate dehydrogenase and LL-diaminopimelate epimerase.

Luke K. T. Lam, Lee D. Arnold, Thomas H. Kalantar et al. · Journal of Biological Chemistry · 1988 · 57 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Subtle effects in the asymmetric epoxidation: dependence of kinetic resolution efficiency on the monodentate alkoxide ligands of the bystander titanium center

Blaine H. McKee, Thomas H. Kalantar, K. Barry Sharpless · The Journal of Organic Chemistry · 1991 · 39 citations

Natural Sciences, Chemistry, Catalysis +10

1–5 of 13